Arkea Bio Corp.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Arkea Bio Corp. - overview
Established
2022
Location
Charlestown, MA, US
Primary Industry
Biotechnology
About
Founded in 2022 and based in Massachusetts, US, Arkea Bio Corp. operates as a research and development company in the fields of climate change, greenhouse gases, greenhouse gas reduction, greenhouse gas mitigation, and the prevention and inhibition of methane and greenhouse gas production. As of 2022, Colin South is the CEO of the company. In December 2022, Arkea Bio Corp.
raised USD 12 million in seed funding from Breakthrough Energy Ventures. The company uses vaccination technology to develop solutions to minimise on-farm methane emissions, which contribute to global GHG emissions. The firm's technology can be linked into proven delivery systems and farming techniques to safely reduce global methane emissions from a wide range of different species across geographies and agronomic systems. The organization plans to use the December 2022 funding to accelerate its research program and expand globally.
Current Investors
Breakthrough Energy Ventures, Grantham Foundation, AgTech Innovation Partners
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Agribusiness
Website
www.arkeabio.com
Verticals
Agtech, Clean Technology
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.